SGLT2i Diabetic Treatment One Year Out: What Have We Learned?
SGLT2 inhibitors were introduced to the market over one year ago for the treatment of diabetes mellitus in cats. Since then, we’ve learned a lot about the use of these medications. As a result, patient screening and monitoring protocols have been revised. Join Dr. Cynthia R. Ward, VMD, PhD, DACVIM (SAIM), Professor Emerita, University of Georgia, to discuss SGLT2 inhibitor use, including specific case examples.
In this webinar, we’ll cover:
This webinar is pending RACE approval for 1 CE hour.
In this webinar, we’ll cover:
- Current patient screening recommendations for the use of SGLT2 inhibitors in diabetic cats
- Current monitoring recommendations when using SGLT2 inhibitors in diabetic cats
- When an SGLT2 inhibitor is appropriate, versus traditional insulin therapy
This webinar is pending RACE approval for 1 CE hour.
